DK0719276T3 - Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf - Google Patents
Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold derafInfo
- Publication number
- DK0719276T3 DK0719276T3 DK94928126T DK94928126T DK0719276T3 DK 0719276 T3 DK0719276 T3 DK 0719276T3 DK 94928126 T DK94928126 T DK 94928126T DK 94928126 T DK94928126 T DK 94928126T DK 0719276 T3 DK0719276 T3 DK 0719276T3
- Authority
- DK
- Denmark
- Prior art keywords
- well
- pharmaceutical preparations
- preparations containing
- estradiol esters
- oral action
- Prior art date
Links
- 150000002159 estradiols Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- QOXSQPRKRVDCHK-GXEDQJNUSA-N (8r,9s,10r,13s,14s)-13-methyl-7,8,9,10,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical class C1=C(O)C=C[C@@H]2[C@H]3CC[C@](C)(C(CC4)O)[C@@H]4[C@@H]3CC=C21 QOXSQPRKRVDCHK-GXEDQJNUSA-N 0.000 abstract 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- 230000001076 estrogenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/122,853 US5554603A (en) | 1993-09-17 | 1993-09-17 | Orally active derivatives of 1,3,5(10)-estratriene |
| PCT/US1994/010393 WO1995007925A1 (en) | 1993-09-17 | 1994-09-15 | Orally active derivatives of 1,3,5(10)-estratriene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0719276T3 true DK0719276T3 (da) | 1998-08-10 |
Family
ID=22405185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94928126T DK0719276T3 (da) | 1993-09-17 | 1994-09-15 | Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5554603A (da) |
| EP (1) | EP0719276B1 (da) |
| JP (1) | JP3993228B2 (da) |
| AT (1) | ATE160573T1 (da) |
| AU (1) | AU700576B2 (da) |
| CA (1) | CA2171740C (da) |
| DE (1) | DE69407057T2 (da) |
| DK (1) | DK0719276T3 (da) |
| ES (1) | ES2110258T3 (da) |
| GR (1) | GR3025872T3 (da) |
| WO (1) | WO1995007925A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6548491B2 (en) | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6503896B1 (en) | 1997-12-24 | 2003-01-07 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| US6054446A (en) * | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| DE19906159A1 (de) * | 1999-02-09 | 2000-08-10 | Schering Ag | 16-Hydroxyestratriene als selektiv wirksame Estrogene |
| EP1603933A2 (en) * | 2003-03-13 | 2005-12-14 | Nitromed, Inc. | Nitrosated and nitrosylated compounds, compositions and methods of use |
| AU2005247948A1 (en) * | 2004-05-27 | 2005-12-08 | Migenix Corp. | 2-substituted 17-imino estrogen compounds for cytoprotection |
| EP2265629B1 (en) * | 2008-03-05 | 2015-06-24 | Evestra, Inc. | Bismethylene-17 carbolactones and related uses |
| WO2009132208A1 (en) * | 2008-04-24 | 2009-10-29 | Evestra, Inc. | Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen |
| US8222237B2 (en) * | 2008-11-25 | 2012-07-17 | Evestra, Inc. | Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones |
| AU2011238710B2 (en) * | 2010-03-28 | 2015-08-20 | Evestra, Inc. | Intravaginal drug delivery device |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1074493A (en) * | 1963-06-12 | 1967-07-05 | Roussel Uclaf | Novel estrane derivatives and processes for preparing them |
| FR5241M (da) * | 1966-02-24 | 1967-07-17 | ||
| NL135316C (da) * | 1966-11-18 | |||
| GB1332784A (en) * | 1969-11-21 | 1973-10-03 | Glaxo Lab Ltd | Nitrates of steroid 11 beta-ols |
| US3980681A (en) * | 1969-11-21 | 1976-09-14 | Peter Job Sykes | Process for the preparation of 11-β-nitro-oxysteroids |
| US4705783A (en) * | 1985-06-25 | 1987-11-10 | Sri International | 9α, 11β-substituted and 11β-substituted estranes |
-
1993
- 1993-09-17 US US08/122,853 patent/US5554603A/en not_active Expired - Lifetime
-
1994
- 1994-09-15 ES ES94928126T patent/ES2110258T3/es not_active Expired - Lifetime
- 1994-09-15 EP EP94928126A patent/EP0719276B1/en not_active Expired - Lifetime
- 1994-09-15 JP JP50933695A patent/JP3993228B2/ja not_active Expired - Fee Related
- 1994-09-15 DK DK94928126T patent/DK0719276T3/da active
- 1994-09-15 WO PCT/US1994/010393 patent/WO1995007925A1/en not_active Ceased
- 1994-09-15 AT AT94928126T patent/ATE160573T1/de not_active IP Right Cessation
- 1994-09-15 AU AU77284/94A patent/AU700576B2/en not_active Expired
- 1994-09-15 DE DE69407057T patent/DE69407057T2/de not_active Expired - Lifetime
- 1994-09-15 CA CA002171740A patent/CA2171740C/en not_active Expired - Lifetime
-
1998
- 1998-01-12 GR GR980400045T patent/GR3025872T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE160573T1 (de) | 1997-12-15 |
| EP0719276A1 (en) | 1996-07-03 |
| JP3993228B2 (ja) | 2007-10-17 |
| WO1995007925A1 (en) | 1995-03-23 |
| GR3025872T3 (en) | 1998-04-30 |
| CA2171740C (en) | 2005-07-26 |
| ES2110258T3 (es) | 1998-02-01 |
| DE69407057D1 (de) | 1998-01-08 |
| AU7728494A (en) | 1995-04-03 |
| AU700576B2 (en) | 1999-01-07 |
| JPH09505802A (ja) | 1997-06-10 |
| CA2171740A1 (en) | 1995-03-23 |
| US5554603A (en) | 1996-09-10 |
| DE69407057T2 (de) | 1998-04-09 |
| EP0719276B1 (en) | 1997-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL193616B (nl) | Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten. | |
| OA09458A (en) | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof. | |
| IL87885A (en) | Pharmaceutical compositions having antiprogestational and anti-estrogenic activities for the treatment of hormone- dependent tumors | |
| AU635358B2 (en) | Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole | |
| TW229208B (da) | ||
| UA39158C2 (uk) | Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі | |
| MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
| ZA965752B (en) | Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents. | |
| IL109901A0 (en) | Peptidic phosphinyloxymethyl ketones and pharmaceutical compositions containing them | |
| AU674378B2 (en) | Use of 2-amino-6-A-propylamino-4,5,6, 7-tetrahydrobenzothiazole (pramipexol) as an anti-depressantdrug | |
| WO1997004788A3 (en) | Use of calendula glycosides for the treatment of psoriasis | |
| NO972391D0 (no) | 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav | |
| DK0719276T3 (da) | Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf | |
| ZA93821B (en) | New derivatives of baccatin III and of 10-deacetyibaccatin III, their preparation and the pharmaceutical compositions which contain them. | |
| AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
| HUT41002A (en) | Process for preparing anticonvulsives | |
| DK99987A (da) | Oestrogenpraeparater | |
| ZA929879B (en) | Compositions for the treatment of mammalian diseases. | |
| TW218011B (da) | ||
| PT83253A (en) | Process for preparing p-acylaminobenzamides | |
| TR25423A (tr) | DAHA AKTIF TüRLERI BAKIMINDAN ZENGINLESTIRILMIS SIPERMETRIN VEYA SIFLUTRIN ISOMERLERININ KARISIMLARININ HAZIRLANMASI. | |
| ATE204286T1 (de) | Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge | |
| IL101540A0 (en) | Method and composition for the treatment of herpes related disorders | |
| IE873354L (en) | New pyrrolobenzimidazoles, processes for the preparation¹thereof and pharmaceutical compositions containing them. | |
| IT8919204A0 (it) | Composizione per la prevenzione e la cura di parodontopatte. |